Futu News on December 10th, this Friday. $YONGHE MEDICAL (02279.HK)$Announcement: The company issued 94.424 million shares at a price of HK$15.8 per share, in lots of 500 shares, expected to be listed on December 13th.
During the public offering stage, Yonghe Medical received approximately 160.06 times oversubscription, with a final allocation of 47.212 million shares for public offering, accounting for 50% of the total shares available for public offering (before any exercise of the over-allotment option). A total of 81,126 valid applications were received, with a 15% allotment rate, allowing the subscription of 16 lots for stability.
In addition, the international offering shares were oversubscribed by approximately 8.39 times, with a final allocation of 47.212 million shares for international offering, equivalent to 50% of the total shares available for public offering (before any exercise of the over-allotment option). Futu News has compiled the relevant data in the table below:
The net income of approximately 1.357 billion Hong Kong dollars will be used for the following purposes: about 42.1% will be used to expand and upgrade the company's existing hair transplant medical institutions in China; about 17.5% will be used to provide funds for product and service innovation projects; about 9.7% will be invested in research and development, and to enhance its service system with cutting-edge technology; about 23.4% will be used to integrate industry resources in China to enhance brand awareness; about 1.6% will be used to settle the unpaid balance of the acquisition cost of the prominent hair transplant affiliated with Xin Siyu which the company acquired in May 2021; about 5.7% will be used for operating funds and general corporate purposes...